Biosimilar Comparability Gaps? Analytical and Regulatory Pathway Solutions
Addressing Comparability Gaps in Biosimilars: Analytical and Regulatory Pathway Solutions Biosimilars offer promising opportunities in therapeutic efficacy while being cost-effective alternatives to original biologics. However, concerns about comparability can arise…